Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents.
Bergheanu SC, Pons D, van der Hoeven BL, Liem SS, Siegerink B, Schalij MJ, van der Bom JG, Jukema JW. Bergheanu SC, et al. Among authors: van der hoeven bl, van der bom jg. Heart Vessels. 2011 May;26(3):235-41. doi: 10.1007/s00380-010-0046-8. Epub 2010 Oct 30. Heart Vessels. 2011. PMID: 21052690 Clinical Trial.
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ. van der Hoeven BL, et al. Among authors: van der wall ee. J Am Coll Cardiol. 2008 Feb 12;51(6):618-26. doi: 10.1016/j.jacc.2007.09.056. J Am Coll Cardiol. 2008. PMID: 18261680 Free article. Clinical Trial.
Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.
van der Hoeven BL, Liem SS, Dijkstra J, Bergheanu SC, Putter H, Antoni ML, Atsma DE, Bootsma M, Zeppenfeld K, Jukema JW, Schalij MJ. van der Hoeven BL, et al. JACC Cardiovasc Interv. 2008 Apr;1(2):192-201. doi: 10.1016/j.jcin.2008.02.003. JACC Cardiovasc Interv. 2008. PMID: 19463300 Free article. Clinical Trial.
Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study.
Atary JZ, Bergheanu SC, van der Hoeven BL, Atsma DE, Bootsma M, van der Kley F, Zeppenfeld K, Jukema JW, Schalij MJ. Atary JZ, et al. Among authors: van der hoeven bl, van der kley f. EuroIntervention. 2009 Nov;5(5):565-72. doi: 10.4244/eijv5i5a92. EuroIntervention. 2009. PMID: 20142177 Clinical Trial.
Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study).
Atary JZ, van der Hoeven BL, Liem SS, Jukema JW, van der Bom JG, Atsma DE, Bootsma M, Zeppenfeld K, van der Wall EE, Schalij MJ. Atary JZ, et al. Among authors: van der wall ee, van der hoeven bl, van der bom jg. Am J Cardiol. 2010 Jul 1;106(1):4-12. doi: 10.1016/j.amjcard.2010.02.005. Epub 2010 May 13. Am J Cardiol. 2010. PMID: 20609639 Clinical Trial.
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
Boden H, van der Hoeven BL, Liem SS, Atary JZ, Cannegieter SC, Atsma DE, Bootsma M, Jukema JW, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ. Boden H, et al. Among authors: van der wall ee, van der hoeven bl. EuroIntervention. 2012 Jan;7(9):1021-9. doi: 10.4244/EIJV7I9A164. EuroIntervention. 2012. PMID: 22207227 Free article. Clinical Trial.
Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients.
Velders MA, Boden H, van der Hoeven BL, Liem SS, Atary JZ, van der Wall EE, Jukema JW, Schalij MJ. Velders MA, et al. Among authors: van der wall ee, van der hoeven bl. EuroIntervention. 2013 Feb 22;8(10):1199-206. doi: 10.4244/EIJV8I10A184. EuroIntervention. 2013. PMID: 23425544 Free article.
47 results